Drug guide

Fosamprenavir

Fosamprenavir ( fos-am-PREN-a-veer) is a protease inhibitor. It is used in combination with other medicines to treat patients who are infected with the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Fosamprenavir may slow down the destruction of the immune system caused by HIV. This may help delay the development of problems usually related to AIDS or HIV disease. However, Fosamprenavir will not cure or prevent HIV infection, and it will not keep you from spreading the virus to other people. Patients who are taking Fosamprenavir may continue to have the problems usually related to AIDS or HIV disease. Fosamprenavir is available only with your doctor's prescription, in the following dosage forms: Oral Tablets (U.S.)

Fosamprenavir is used with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired immunodeficiency syndrome (AIDS). Fosamprenavir is in a class of medications called protease inhibitors. It works by slowing the spread of HIV in the body. Fosamprenavir does not cure HIV infection and may not prevent you from developing HIV-related illnesses. Fosamprenavir does not prevent you from spreading HIV to other people.

Fosamprenavir comes as a tablet to take by mouth. It is usually taken with or without food once or twice a day. To help you remember to take Fosamprenavir, take it around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take Fosamprenavir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Fosamprenavir controls HIV infection but does not cure it. Continue to take Fosamprenavir even if you feel well. Do not stop taking Fosamprenavir without talking to your doctor. If you miss doses or stop taking Fosamprenavir, your condition may become more difficult to treat.

Brand names:
- Fosamprenavir
- LEXIVA